Position in MNKD
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$21,126,835
+$10,612,163 QoQ
Shares Held
4,959,351
+15.6% QoQ
Ownership
1.54%
of shares outstanding
% of Portfolio
2.84%
of 13F equity value
Holder Rank
#9
of 254 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 69%
Shared 0%
None 31%
Common Shares in MNKD Over Time
Shares Held
Position Value (USD)
Derivatives in MNKD
reported options exposure · as of Jun 30, 2026CallValue
$2,130
CallShares
500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026180 WEALTH ADVISORS, LLC holds $26,828,326 across 11 Biotechnology names. MNKD ranks #1 (78.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MNKD |
Mannkind Corp
This page
|
4,959,351 | $21,126,835 | |
| 2 | MRNA |
Moderna, Inc.
|
35,750 | $2,503,572 | |
| 3 | INCY |
Incyte Corp
|
7,045 | $798,621 | |
| 4 | RXRX |
Recursion Pharmaceuticals, Inc.
|
190,562 | $699,362 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
7,257 | $395,796 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
8,753 | $341,454 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
548 | $272,208 | |
| 8 | EXEL |
Exelixis, Inc.
|
4,266 | $232,113 |
All Filings in MNKD
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,130 | 500 | Call | Sole | 2026-07-07 | |
| 2026-06-30 | $21,126,835 | 4,959,351 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $10,514,672 | 4,291,703 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $16,777,212 | 2,958,944 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $15,424,175 | 2,872,286 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $9,656,717 | 2,582,010 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $11,039,361 | 2,194,704 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $13,539,696 | 2,105,707 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $13,111,737 | 2,084,537 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $10,618,179 | 2,034,134 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $8,798,211 | 1,942,210 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $6,280,201 | 1,725,330 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $6,531,471 | 1,581,470 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $6,272,940 | 1,541,263 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $6,078,815 | 1,482,638 | Shares | Sole | 2023-04-07 | |
| 2022-12-31 | $7,737,134 | 1,468,147 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $4,589,685 | 1,485,335 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $5,485,881 | 1,439,864 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $5,041,246 | 1,369,904 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $4,533,551 | 1,037,426 | Shares | Sole | 2022-01-26 | |
| 2021-12-31 | $2,185 | 500 | Call | Sole | 2022-01-26 | |
| 2021-09-30 | $2,175 | 500 | Call | Sole | 2021-10-28 | |
| 2021-09-30 | $3,999,629 | 919,455 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $4,842,455 | 888,524 | Shares | Sole | 2021-08-13 | |
| 2021-06-30 | $2,725 | 500 | Call | Sole | 2021-08-13 | |
| 2021-03-31 | $2,961,336 | 755,443 | Shares | Sole | 2021-05-25 | |
| 2020-12-31 | $1,937,548 | 619,025 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $939,044 | 499,492 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $836,470 | 477,983 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $448,895 | 435,821 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||